Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,532 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
High‑net‑worth investors are leaning on tax‑aware planning this year. The playbook centers on advisor guidance, tax‑e...
Dell Technologies stunned markets with a Q1 FY27 results beat, led by AI-optimized servers and a rising backlog. The ...
A retiree couple taking in $9,500 per month sits on the edge of the 12%/22% federal tax brackets, where withdrawal ch...
A wave of AI-driven disruption arrived years early—now forcing employers and households to rethink careers, savings, ...
A 29-year-old AI investor has steered a hedge fund to $20 billion with a reported 1,000% return since inception. This...
As markets swing and tax rules shift, households with a $450K+ 401K are weighing year-end charity moves. A Donor-Advi...
A focused duplex hunt in St. Louis turned into an eight-unit treasure, thanks to bold moves, solid numbers, and a kna...
SBI Group unveils JPYSC, the first trust-bank-backed yen stablecoin in Japan, with a 1:1 peg to the yen and no transa...
Bridgewater Associates pivots its recruiting to emphasize resilience, drawing on Ray Dalio’s own history as a ‘terrib...
A disturbing case shows how a city inspector could steer repair funds to relatives. This article breaks down what hap...
A new watchdog analysis shows lawmakers traded on information tied to pending votes, raising questions about ethics a...